Site icon COINWECK

Windtree Therapeutics Commits Up to $700M to BNB Crypto Treasury Strategy”

Windtree Therapeutics Commits Up to $700M to BNB Crypto Treasury Strategy”

Windtree Therapeutics Commits Up to $700 Million Toward BNB Acquisitions in Strategic Crypto Treasury Initiative
99% of proceeds from new financing agreements earmarked for BNB purchases

WARRINGTON, Pa., July 24, 2025— Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company pursuing innovation through strategic diversification, today announced two major financing agreements totaling up to $700 million—with nearly all proceeds intended for BNB cryptocurrency acquisitions as part of its growing digital asset treasury strategy.

The company has entered into a Common Stock Purchase Agreement to establish a $500 million Equity Line of Credit (ELOC) and a separate $20 million stock purchase agreement with Build and Build Corp. Windtree plans to allocate 99% of the total proceeds from both deals to purchase BNB, pending shareholder approval to increase its authorized share count—a requirement before the ELOC can be utilized.

“We’re excited to leverage these facilities to advance our BNB treasury strategy,” said Jed Latkin, CEO of Windtree. “Pending shareholder approval, these funds will significantly support our long-term vision for integrating digital assets into our balance sheet.”

Strengthening a Forward-Thinking Treasury Strategy

This move marks a significant step in Windtree’s broader plan to diversify its corporate treasury through digital assets. The company sees blockchain-based currencies like BNB as a strategic hedge and a potential source of value creation, aligning with its mission to explore innovative financial management practices.

“Windtree’s vision to integrate BNB into its treasury is a progressive approach to unlocking value,” said Patrick Horsman, CFA, Director of Build and Build Corp. “The scale and flexibility of the ELOC structure empower the company to execute on its digital asset strategy effectively.”

About Windtree Therapeutics, Inc.

Windtree Therapeutics is a diversified biotechnology company focused on advancing its two key therapeutic pipelines while strategically building a cryptocurrency treasury. The company is actively exploring development partnerships for its clinical assets and expanding into innovative financial strategies.

About Build and Build Corp.

Build and Build Corp is a digital asset and hedge fund-focused firm founded by Patrick Horsman, Joshua Kruger, and Johnathan Pasch, collectively bringing over 43 years of experience in investment management. The firm is backed by notable investors, including Discovery Capital, Kraken, Galaxy Digital, Off The Chain Capital, Gaia Digital Asset, and Silvermine, and is committed to pioneering innovative financial solutions.


Forward-Looking Statements
This release includes forward-looking statements based on current expectations and projections. These statements involve risks and uncertainties, including those related to regulatory approvals, market conditions, and execution of the company’s crypto treasury strategy. Actual outcomes may differ materially. For a full list of risk factors, see Windtree’s filings with the Securities and Exchange Commission at www.sec.gov. The company assumes no obligation to update these statements following the date of this release.

Disclaimer and Risk Warning
CoinWack does not endorse or is responsible for any content, accuracy, quality, advertising, products, or other materials on this page. The image used in this article is for informational purposes only and is provided to us by a third party. CoinWack should not be held responsible for image copyright issues. Contact us if you have any issues or concerns. Readers should do their research before taking any actions related to the company.

Exit mobile version